{"id":240953,"date":"2026-09-10T12:53:13","date_gmt":"2026-09-10T07:23:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=240953"},"modified":"2026-09-10T12:53:13","modified_gmt":"2026-09-10T07:23:13","slug":"is-epigral-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-epigral-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Epigral a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Epigral share price around Rs 1,147. 36.6% below 52-week high of Rs 1,809. Q1 FY27 revenue Rs 709 crore, up 15.4% YoY. PAT Rs 100 crore, down 37.9%. PE 18x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Epigral’s Q1 FY27 results were mixed, with revenue at Rs 709 crore but PAT falling 38% to Rs 100 crore. The Epigral share price near Rs 1,147 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Epigral is a good buy right now.<\/p>\n<\/p><\/div>\n

The Epigral share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Epigral is formerly Meghmani Finechem, a leading integrated manufacturer of chlor-alkali and specialty chemicals, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 709 crore, up 15.4% year on year, while profit after tax came in at Rs 100 crore, down 37.9% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Epigral share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Epigral share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n